FOLD

Amicus Therapeutics, Inc.

10.66 USD
+0.01 (+0.09%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Amicus Therapeutics, Inc. stock is up 9.11% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 17 July’s closed higher than June. In the last 10 Unusual Options Trades, there were 10 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Jul 13:47 17 Jan, 2025 8.00 CALL 200 360
05 Jul 13:52 18 Oct, 2024 8.00 CALL 150 455
05 Jul 13:53 18 Oct, 2024 9.00 CALL 200 2595
05 Jul 15:34 18 Oct, 2024 9.00 CALL 200 2595
10 Jul 15:25 18 Oct, 2024 9.00 CALL 148 2003
10 Jul 15:40 18 Oct, 2024 8.00 CALL 100 305
11 Jul 13:30 18 Oct, 2024 9.00 CALL 350 1855
11 Jul 13:30 18 Oct, 2024 9.00 CALL 194 1855
15 Jul 15:21 18 Oct, 2024 9.00 CALL 150 988
16 Jul 13:30 18 Oct, 2024 9.00 CALL 130 986

About Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases.